Skip to main content
. 2021 Feb 22;26(5):362–e724. doi: 10.1002/onco.13689
Capecitabine
Generic/Working Name Capecitabine
Trade Name Xeloda
Company Name Roche
Drug Type Fluoropyrimidine with antineoplastic activity
Drug Class Antimetabolite
Dose 1,000 milligrams (mg) per squared meter (m2)
Route Oral (p.o.)
Schedule of Administration Capecitabine was administered at 1,000 mg/m2 by mouth twice daily. The dose of capecitabine was calculated with a maximum body surface area (BSA) of 2.0 m2 for patient safety. Capecitabine dose was adjusted if BSA changed >5% from baseline.
Sorafenib
Generic/Working Name Sorafenib
Trade Name Nexavar
Company Name Bayer and Onyx Pharmaceutics
Drug Type Small molecule
Drug Class Tyrosine kinase inhibitor
Dose 200 milligrams
Route Oral (p.o.)
Schedule of Administration Sorafenib was administered at 200 mg by mouth twice daily. Dose was increased to 400 mg by mouth each morning and 200 mg by mouth each evening (dose level + 1) for cycle 2, and then to 400 mg by mouth twice daily (dose level + 2) for cycle 3 and onward, assuming no attributable AEs during the prior cycle.